EarningsQ1 2023 Earnings Report

Eledon Pharmaceuticals (2TK) Q1 2023 Earnings Report

1 Followers

DE:2TK Q1 2023 EPS Results

Actual EPS-€0.67

Consensus EPS-€0.57

Beat/MissMissed by -€0.10

One Year Ago EPS-€0.62

Actual Revenue€0.00

Expected Revenue€0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ1 2023

Date05/11/2023

TimeAfter Close

Conference CallThursday, May 11, 2023

DE:2TK Upcoming Earnings

Eledon Pharmaceuticals's next earnings date is estimated for November 18, 2026, based on past reporting schedules.

DE:2TK Q1 2023 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 18, 2026	2026 (Q3)	-0.17 / -	-0.187	―
Aug 13, 2026	2026 (Q2)	-0.14 / -0.24	-0.116	-107.69% (-0.12)
May 13, 2026	2026 (Q1)	-0.16 / -0.29	-0.071	-312.50% (-0.22)
Mar 19, 2026	2025 (Q4)	-0.18 / -0.10	-0.571	82.81% (+0.47)
Nov 14, 2025	2025 (Q3)	-0.22 / -0.19	-0.286	34.38% (+0.10)
Aug 14, 2025	2025 (Q2)	-0.21 / -0.12	-0.946	87.74% (+0.83)
May 14, 2025	2025 (Q1)	-0.23 / -0.07	-0.303	76.47% (+0.23)
Mar 20, 2025	2024 (Q4)	-0.28 / -0.57	-0.286	-100.00% (-0.29)
Nov 12, 2024	2024 (Q3)	-0.28 / -0.29	-0.312	8.57% (+0.03)
Aug 08, 2024	2024 (Q2)	-0.27 / -0.32	-0.357	10.00% (+0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed